All Articles

Lummus Technology's acquisition of Shell's emissions control unit is more than a simple transaction; it's a calculated move to dominate the industrial decarbonization market.

A junior miner, backed by Rio Tinto, is drilling for copper in a historic Montana district. It's a high-risk bet on a metal vital for our digital future.

Priority Technology reports impressive revenue growth, yet its GAAP profits are falling. A deep dive into the fintech's complex financials reveals its strategy.

Follett Software embeds AI into its K-12 platform at no cost, promising efficiency. But a closer look reveals a strategy that may reshape EdTech budgets.

As a major cyclospora outbreak sweeps the U.S., Roche's new research-only PCR tests provide a critical, behind-the-scenes tool for public health.

A critical safety milestone for PepGen’s PGN-EDODM1 offers a glimmer of hope for myotonic dystrophy patients and highlights a novel strategy in a competitive field.

Distribution Solutions Group announces a take-private deal with an 81% premium, fueled by strong earnings. A look at the strategy behind the move.

Rare Beauty Brands and JCPenney's LIFT accelerator isn't just about funding; it's a systemic blueprint for diversifying an industry from the ground up.

Pollo AI's new Agent 2.0 moves beyond simple generation, acting as an intelligent coordinator for video production. Is this the future of marketing content?

NexPoint thrives amid credit market turmoil by pairing cycle-resistant assets with a high-yield lending offensive, revealing a durable model for value creation.

Facing crippling new U.S. tariffs, a Canadian brand isn't just surviving—it's building a coalition. Miik's "Keep it Canadian" challenge is a masterclass.

While others chase scale, Netgain proves that deep expertise in regulated sectors like healthcare and legal is the key to sustained growth and industry leadership.

As AI adoption outpaces governance, a new firm is creating a credit score-like system for AI risk. With a high-powered advisory board, is this the key to resilience?

MacPaw's Moonlock didn't just win; it swept the Stevie Awards. This triple victory for its team, talent, and tech reveals a deeper strategy for Mac users.

A "Product of the Year" award for a dog treat is more than just news. It reveals a deep shift in corporate strategy and the growing pet wellness system.

With the launch of its TED drug Lumvoa, Viridian Therapeutics steps into the commercial ring. But can early momentum and a deep pipeline justify the cost?

Genius Sports raises its outlook on soaring revenue post-acquisition, but a deeper look reveals widening losses. Can its strategic bet on data and media pay off?

With $60M in new funding and veteran pharma execs on board, Vedanta Biosciences is set for the pivotal last leg of its Phase 3 trial for VE303.

GPGI's Q2 results show a tale of two subsidiaries. While fintech darling CompoSecure hits records, industrial giant Husky faces market drag. Can one system steer both?

BKV Corp. is building a new energy model, using robust gas profits to fund an ambitious expansion into power generation and carbon capture technology.